17-hydroxy-6-methylenepregn-4-ene-3,20-dione 17-acetate

‌Megestrol Intermediate | GMP-Certified API Synthesis | USP/EP-Compliant‌
✦✦✦✦✦✦✦✦✦✦✦✦✦✦✦✦

‌Product Overview‌
Megestrol Intermediate is a high-purity chemical precursor essential for synthesizing megestrol acetate, a progesterone analogue widely used in hormonal therapies and oncology treatments‌13. It ensures precision in API manufacturing for contraceptive drugs, cancer therapies, and hormone replacement formulations‌25.

‌Key Advantages‌
✔ ‌>99% HPLC Purity‌: Batch-specific chromatographic validation with full traceability‌34.
✔ ‌GMP/ICH Compliance‌: Produced under ISO 9001 and ICH Q7 guidelines for pharmaceutical-grade quality‌25.
✔ ‌Scalable Synthesis‌: Supports bulk production with 98% yield optimization‌36.

‌Applications‌
◈ ‌Contraceptive API synthesis‌ (e.g., oral contraceptives, hormonal IUDs)‌25.
◈ ‌Oncology drug development‌ (adjuvant therapy for breast/endometrial cancer)‌36.
◈ ‌Veterinary hormone formulations‌ (appetite stimulants for companion animals)‌56.

‌Quality Certifications‌
◼ ‌USP/EP/ICH compliant‌: Full analytical profiles (NMR, IR, MS)‌34.
◼ ‌Stability tested‌: 36-month shelf life under controlled storage (2-8°C)‌25.

‌Market Trends‌
The global hormonal therapy market is projected to reach ‌$45.2B by 2030‌, driven by rising demand for oncology and reproductive health solutions‌56. Megestrol acetate holds ‌22% share in progesterone-based cancer therapies‌, with 15% annual growth in contraceptive API demand‌35.

✦✦✦✦✦✦✦✦✦✦✦✦✦✦✦✦
Optimized Keywords:

• ‌Hormonal Therapy Intermediate‌
• ‌Contraceptive API Synthesis‌
• ‌Oncology Drug Precursor‌
• ‌USP/EP-Compliant Megestrol‌
• ‌GMP-Certified Progesterone Analog‌

Additional High-Value Keywords:

• High-Yield Hormone Synthesis

• Veterinary Pharmaceutical Grade

• Breast Cancer Adjuvant Intermediate

• Oral Contraceptive Manufacturing

• Stability-Validated API Precursor